ACO-SWITCH Trial to Track Serum Transthyretin After Tafamidis-to-Acoramidis Switch
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults ...
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults ...
A chart review of 54 patients with hereditary transthyretin amyloidosis found that only a third of coded polyneuropathy diagnoses were ...
A retrospective US claims analysis found that newly treated ATTR-CM patients starting acoramidis had significantly lower risks of diuretic intensification ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.